Manon M. H. Huibers
Papers
1
Total Citations
86
H-Index
1
About
Manon M. H. Huibers is a leading translational researcher at the intersection of cancer genomics and precision diagnostics. Her work centers on the clinical implementation of whole genome sequencing (WGS) to transform how tumors are genetically characterized. In her landmark 2021 study, “Clinical Validation of Whole Genome Sequencing for Cancer Diagnostics” (86 citations), Huibers demonstrated that WGS using fresh-frozen tissue and matched blood samples can serve as a comprehensive, all-inclusive genetic test—a pivotal step toward replacing fragmented biomarker panels with a single, unified assay. This contribution is especially critical as oncology moves toward smaller biopsies and the need for broader genomic profiling grows. Her research directly addresses the practical challenges of integrating high-throughput sequencing into routine clinical workflows, bridging the gap between technological capability and patient care. Beyond this validation work, Huibers has been instrumental in advancing standards for tumor-normal sequencing and advocating for the adoption of WGS in diagnostic settings. Her efforts are shaping a future where cancer diagnostics are faster, more complete, and more equitable, making her a key voice in the evolution of precision oncology.
Research Focus
Key Achievements
Top Papers
- 1Clinical Validation of Whole Genome Sequencing for Cancer Diagnostics86 citations · 2021